Search Results

Miriplatin 100mg  | ≥98%

CSNpharm

Miriplatin is a platinum complex used in TACE that shows promise for the treatment of hepatocellular carcinoma (HCC).

More Information Supplier Page

Miriplatin 50mg  | ≥98%

CSNpharm

Miriplatin is a platinum complex used in TACE that shows promise for the treatment of hepatocellular carcinoma (HCC).

More Information Supplier Page

Miriplatin 5mg  | ≥98%

CSNpharm

Miriplatin is a platinum complex used in TACE that shows promise for the treatment of hepatocellular carcinoma (HCC).

More Information Supplier Page

Miriplatin 10mg  | ≥98%

CSNpharm

Miriplatin is a platinum complex used in TACE that shows promise for the treatment of hepatocellular carcinoma (HCC).

More Information Supplier Page

IB-MECA 2mg  | ≥99%

CSNpharm

IB-MECA is an agonist of the adenosine A3 receptor with EC50 values of 0.11 μM. IB-MECA is a potent and selective A3 adenosine receptor agonist with Ki value of 1.1, 54 and 56 nM for A3, A1 and A2A receptors, respectively, which possessing cardioprotective effect and reduces infarct size upon reperfusion in rats.

More Information Supplier Page

IB-MECA 10mg  | ≥99%

CSNpharm

IB-MECA is an agonist of the adenosine A3 receptor with EC50 values of 0.11 μM. IB-MECA is a potent and selective A3 adenosine receptor agonist with Ki value of 1.1, 54 and 56 nM for A3, A1 and A2A receptors, respectively, which possessing cardioprotective effect and reduces infarct size upon reperfusion in rats.

More Information Supplier Page